MAPT and Alzheimer disease: Alzheimer’s disease is characterized by a massive loss of neurons in the brain that is accompanied by extensive pathological aggregates, i.e., SPs and NFTs containing Aβ38–43- and hyperphosphorylated tau versions, respectively.